In addition, GTCpFE was found to inhibit NFκB activity in other breast cancer cell lines, such as BT474 and MDA-MB-231 (Fig. 3e, f), and in response to other cytokines, including IL-1β (Additional file 3: Figure S2). Here, NFKB1 is linked to breast cancer.